...
首页> 外文期刊>Strahlentherapie und Onkologie >Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy
【24h】

Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy

机译:用于预测辐射诱导肺癌患者肺癌患者肺癌患者肺损伤的辐射瘤分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives To predict radiation-induced lung injury and outcome in non-small cell lung cancer (NSCLC) patients treated with robotic stereotactic body radiation therapy (SBRT) from radiomic features of the primary tumor. Methods In all, 110 patients with primary stage I/IIa NSCLC were analyzed for local control (LC), disease-free survival (DFS), overall survival (OS) and development of local lung injury up to fibrosis (LF). First-order (histogram), second-order (GLCM, Gray Level Co-occurrence Matrix) and shape-related radiomic features were determined from the unprocessed or filtered planning CT images of the gross tumor volume (GTV), subjected to LASSO (Least Absolute Shrinkage and Selection Operator) regularization and used to construct continuous and dichotomous risk scores for each endpoint. Results Continuous scores comprising 1-5 histogram or GLCM features had a significant (p= 0.0001-0.032) impact on all endpoints that was preserved in a multifactorial Cox regression analysis comprising additional clinical and dosimetric factors. At 36 months, LC did not differ between the dichotomous risk groups (93% vs. 85%, HR 0.892, 95%CI 0.222-3.590), while DFS (45% vs. 17%, p< 0.05, HR 0.457, 95%CI 0.240-0.868) and OS (80% vs. 37%, p< 0.001, HR 0.190, 95%CI 0.065-0.556) were significantly lower in the high-risk groups. Also, the frequency of LF differed significantly between the two risk groups (63% vs. 20% at 24 months, p< 0.001, HR 0.158, 95%CI 0.054-0.458). Conclusion Radiomic analysis of the gross tumor volume may help to predict DFS and OS and the development of local lung fibrosis in early stage NSCLC patients treated with stereotactic radiotherapy.
机译:目的是预测辐射诱导的非小细胞肺癌(NSCLC)患者的肺损伤和结果,从原发性肿瘤的射线特征中获得机器人立体定向体放射治疗(SBRT)。所有,110例患有110名患有局部阶段I / IIA NSCLC的患者,用于局部对照(LC),无病生存(DFS),整体存活(OS)以及局部肺损伤的发育直至纤维化(LF)。从粗糙的肿瘤体积(GTV)的未加工或过滤的规划CT图像确定一阶(直方图),二阶(GLCM,灰度共发生矩阵)和形状相关的射线特征,经受套索(至少绝对收缩和选择操作员)正规化并用于为每个端点构建连续和二分法风险分数。结果包含1-5直方图或GLCM特征的连续评分对所有终点的所有终点产生显着(p = 0.0001-0.032),该终点包括另外的临床和剂量因子。 36个月,LC在二分风险群(93%对85%,HR 0.892,95%CI 0.222-3.590)之间没有区别,而DFS(45%与17%,P <0.05,HR 0.457,95 %CI 0.240-0.868)和OS(80%对37%,P <0.001,HR 0.190,95%CI 0.065-0.556)在高风险群体中显着降低。此外,LF的频率在两个风险基团之间有显着不同(24个月,P <0.001,HR 0.158,95%CI 0.054-0.458)之间的63%对20%。结论肿瘤总量的辐射瘤分析可能有助于预测DFS和OS,早期NSCLC患者的局部肺纤维化的发展术治疗定向疗法治疗。

著录项

  • 来源
    《Strahlentherapie und Onkologie》 |2019年第9期|共13页
  • 作者单位

    Univ Hosp Cologne Dept Stereotact &

    Funct Neurosurg Kerpener Str 62 D-50937 Cologne Germany;

    Univ Hosp Cologne Dept Radiat Oncol Kerpener Str 62 D-50937 Cologne Germany;

    Univ Hosp Cologne Dept Stereotact &

    Funct Neurosurg Kerpener Str 62 D-50937 Cologne Germany;

    Univ Hosp Cologne Inst Diagnost &

    Intervent Radiol Kerpener Str 62 D-50937 Cologne Germany;

    Univ Hosp Cologne Dept Radiat Oncol Kerpener Str 62 D-50937 Cologne Germany;

    Univ Hosp Cologne Dept Stereotact &

    Funct Neurosurg Kerpener Str 62 D-50937 Cologne Germany;

    Univ Hosp Cologne Dept Stereotact &

    Funct Neurosurg Kerpener Str 62 D-50937 Cologne Germany;

    Univ Hosp Cologne Dept Stereotact &

    Funct Neurosurg Kerpener Str 62 D-50937 Cologne Germany;

    Univ Hosp Cologne Dept Stereotact &

    Funct Neurosurg Kerpener Str 62 D-50937 Cologne Germany;

    Univ Hosp Cologne Dept Stereotact &

    Funct Neurosurg Kerpener Str 62 D-50937 Cologne Germany;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 ger
  • 中图分类 放射医学;
  • 关键词

    Image analysis; Radiobiology; Machine learning; Toxicity; Biomarker;

    机译:图像分析;辐射生物学;机器学习;毒性;生物标志物;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号